EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Lobetyolin Suppressed Osteoclastogenesis and Alleviated Bone Loss in Ovariectomy-Induced Osteoporosis via Hindering p50/p65 Nuclear Translocation and Downstream NFATc1/c-Fos Expression

Chunmei Xiu, Hua Luo, Weixing Huang, Shaohua Fan, Chiting Yuan, Jiangjie Chen, Chenghao Xu, Can Yao, Dun Hong iD, Liwei Zhang iD

Drug Design, Development and Therapy · 2025

DOI: 10.2147/dddt.s515930 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2025. Verfasst von Chunmei Xiu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bone Metabolism, Taizhou Hospital of Zhejiang Province, School of Medicine, Zhejiang University, Taizhou, 317000, People's Republic of C…. Hauptthemen laut MEDLINE: Osteogenesis, Osteoporosis, NF-kappa B p50 Subunit, Bone Resorption. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteogenesisOsteoporosisNF-kappa B p50 SubunitBone ResorptionOsteoporosis, PostmenopausalAnimalsOvariectomyMiceNFATC Transcription FactorsFemaleProto-Oncogene Proteins c-fosOsteoclastsMice, Inbred C57BLTranscription Factor RelACells, CulturedDisease Models, AnimalStructure-Activity RelationshipDose-Response Relationship, DrugMolecular StructureCell Differentiation

Stichwörter der Autor:innen

inflammationlobetyolinosteoblastosteoclastpostmenopausal osteoporosis

Substanzen

NFATC Transcription FactorsProto-Oncogene Proteins c-fosTranscription Factor RelANfatc1 protein, mouseNF-kappa B p50 SubunitFos protein, mouse

Autor:innen und Institutionen

  • Institute of Bone Metabolism, Taizhou Hospital of Zhejiang Province, School of Medicine, Zhejiang University, Taizhou, 317000, People's Republic of China.
  • Department of Clinical Medicine, Key Laboratory of Novel Targets and Drug Study for Neural Repair of Zhejiang Province, School of Medicine, Hangzhou City University, Hangzhou, 310015, People's Republic of China.
  • Orthopedic Department, Taizhou Hospital of Zhejiang Province, School of Medicine, Zhejiang University, Taizhou, 317000, People's Republic of China.
  • General Surgical Department, Taizhou Hospital of Zhejiang Province, School of Medicine, Zhejiang University, Taizhou, 317000, People's Republic of China.
  • Department of Nursing, Zhejiang University School of Medicine First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310000, People's Republic of China.

ORCID-Profile: Dun Hong, Liwei Zhang

Zitieren

APA

Xiu, C., Luo, H., Huang, W., Fan, S., Yuan, C., Chen, J., Xu, C., Yao, C., Hong, D., & Zhang, L. (2025). Lobetyolin Suppressed Osteoclastogenesis and Alleviated Bone Loss in Ovariectomy-Induced Osteoporosis via Hindering p50/p65 Nuclear Translocation and Downstream NFATc1/c-Fos Expression. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s515930

Vancouver

Xiu C, Luo H, Huang W, Fan S, Yuan C, Chen J, et al. Lobetyolin Suppressed Osteoclastogenesis and Alleviated Bone Loss in Ovariectomy-Induced Osteoporosis via Hindering p50/p65 Nuclear Translocation and Downstream NFATc1/c-Fos Expression. Drug Design, Development and Therapy. 2025. doi:10.2147/dddt.s515930

BibTeX
@article{Xiu2025,
  author = {Xiu, Chunmei and Luo, Hua and Huang, Weixing and Fan, Shaohua and Yuan, Chiting and Chen, Jiangjie and Xu, Chenghao and Yao, Can and Hong, Dun and Zhang, Liwei},
  title = {Lobetyolin Suppressed Osteoclastogenesis and Alleviated Bone Loss in Ovariectomy-Induced Osteoporosis via Hindering p50/p65 Nuclear Translocation and Downstream NFATc1/c-Fos Expression},
  journal = {Drug Design, Development and Therapy},
  year = {2025},
  doi = {10.2147/dddt.s515930}
}
Kostenlos starten →